Description
Consider this assay for ultra-sensitive detection of 9 key biomarkers related to inflammation and immune system regulation in human samples. The Human MSD® Discovery Assay® ULTRA HIGH Sensitivity Cytokine Array (MSDUHS) measures IFN-γ, IL-1β, IL-2, IL-4, IL-6, IL-10, IL-12p70, IL-17A, and TNF-α.
This highly sensitive panel is designed for precise analysis of cytokines even at very low concentrations, making it ideal for studying subtle inflammatory responses and immune system dynamics. It is particularly useful in research areas where detecting minor fluctuations in cytokine levels is crucial, such as in chronic inflammatory conditions, autoimmune diseases, and subtle immune alterations.
With its exceptional sensitivity, this assay enables the detection of cytokine levels in the femtogram range, allowing for accurate analysis even when dealing with extremely low concentrations. This makes it a powerful tool for researchers investigating conditions where cytokine expression may be minimal but still clinically significant. Additionally, this assay is optimized for Serum, Plasma, and CSF samples, ensuring compatibility with a wide range of research needs.
For researchers facing challenges with limited sample volumes, this assay provides a solution without sacrificing sensitivity or accuracy. It is particularly advantageous in scenarios where sample quantity is a constraint, offering reliable results from minimal sample input. The assay’s finely tuned detection capabilities ensure that even the most delicate cytokine trends are captured, making it an invaluable resource for in-depth immunological studies.
Whether you’re studying chronic inflammation, autoimmune responses, or other immune-related conditions, the Human MSD® Discovery Assay® ULTRA HIGH Sensitivity Cytokine Array offers unparalleled precision and reliability. For other sample types or specific research needs, please contact us prior to ordering to ensure optimal assay performance.
Published Research Featuring MSD® ULTRA HIGH Sensitivity Cytokine Array:
- Hawerkamp HC, Dyer AH, Patil ND, et al. Characterisation of the pro-inflammatory cytokine signature in severe COVID-19. Frontiers in Immunology, 14, 1170012.
- Edén, A., Grahn, A., Bremell, D., et al. (2022). Viral antigen and inflammatory biomarkers in cerebrospinal fluid in patients with COVID-19 infection and neurologic symptoms compared with control participants without infection or neurologic symptoms. JAMA Network Open, 5(5), e2213253.
- Carter, M., Casey, S., O’Keeffe, G. W., Gibson, L., & Murray, D. M. (2021). Mid-gestation cytokine profiles in mothers of children affected by autism spectrum disorder: A case-control study. Scientific Reports, 11, 22315.
- Zegeye, M. M., Andersson, J. S. O., Wennberg, P., Repsilber, D., Sirsjö, A., & Ljungberg, L. U. (2021). IL-6 as a mediator of the association between traditional risk factors and future myocardial infarction: A nested case-control study. Arteriosclerosis, Thrombosis, and Vascular Biology, 41(4), 1570-1579.